Provided are compositions and methods for treatment of inflammatory autoimmune diseases. The composition comprises fexofenadine or terfenadine, and may further comprise another TNF-α activity inhibitor. The method comprises administering to a subject in need of treatment a therapeutically effective amount of fexofenadine, and optionally another TNF-α activity inhibitor.
